Steroid hormones, receptors, and antagonists

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 1-17

  Jensen, Elwood V ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTIESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; GLUCOCORTICOID RECEPTOR; STEROID HORMONE; STEROID HORMONE RECEPTOR BLOCKING AGENT; STEROID RECEPTOR; TAMOXIFEN;

AMINO TERMINAL SEQUENCE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER REGRESSION; CARBOXY TERMINAL SEQUENCE; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BINDING SITE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METASTASIS; PROGNOSIS; PROTEIN STRUCTURE; RECEPTOR BINDING;

EID: 0029945839     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16223.x     Document Type: Conference Paper

References (68)

1. BEATO, M. 1989. Gene regulation by steroid hormones. Cell 56: 335-344.
2. CARSON-JURICA, M. A., W. T. SCHRADER & B. W. O'MALLEY. 1990. Steroid receptor family: structure and functions. Endocr. Rev. 11: 201-220.
3. PARKER, M. G., Ed. 1991. Nuclear Hormone Receptors. Academic Press. New York/London.
4. JENSEN, E. V. 1991. Steroid hormone receptors. In Current Topics in Pathology. Vol. 83: Cell Receptors. G. Seifert, Ed.: 365-431. Springer-Verlag. Berlin/New York.
5. TSAI, M-J. & B. W. O'MALLEY. 1994. Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
6. JENSEN, E. V. & H. I. JACOBSON. 1960. Fate of steroid estrogens in target tissues. In Biological Activities of Steroids in Relation to Cancer. G. Pincus & E. P. Vollmer, Eds.: 161-178. Academic Press. New York/London.
7. JENSEN, E. V. & H. I. JACOBSON. 1962. Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res. 18: 387-414.
8. MUELLER, G. C., A. M. HERRANEN & K. F. JERVELL. 1957. Studies on the mechanism of action of estrogens. Recent Prog. Horm. Res. 4: 95-139.
9. GORSKI, J. 1992. Remembrance: the introduction of molecular biology and receptors into the study of hormone action. Endocrinology 131: 1583-1584.
10. JENSEN, E. V. 1965. Mechanism of estrogen action in relation to carcinogenesis. Can. Cancer Conf. 6: 143-165.
11. TOFT, D. & J. GORSKI. 1966. A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc. Natl. Acad. Sci. U.S.A. 55: 1574-1581.
12. JENSEN, E. V., M. NUMATA, P. I. BRECHER & E. R. DESOMBRE. 1971. Hormone-receptor interaction as a guide to biochemical mechanism. Biochem. Soc. Symp. 32: 133-159.
13. GORSKI, J., D. TOFT, G. SHYAMALA, D. SMITH & A. NOTIDES. 1968. Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog. Horm. Res. 24: 45-80.
14. JENSEN, E. V., T. SUZUKI, T. KAWASHIMA, W. E. STUMPF, P. W. JUNGBLUT & E. R. DESOMBRE. 1968. A two-step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. U.S.A. 59: 632-638.
15. LITTLE, M., P. I. SZENDRO & P. W. JUNGBLUT. 1973. Hormone-mediated dimerization of microsomal estradiol receptor. Hoppe-Seyler's Z. Physiol. Chem. 354: 1599-1610.
16. NOTIDES, A. C., D. E. HAMILTON & H. E. AUER. 1975. A kinetic analysis of the estrogen receptor transformation. J. Biol. Chem. 250: 3945-3950.
17. MOHLA, S., E. R. DESOMBRE & E. V. JENSEN. 1972. Tissue-specific stimulation of RNA synthesis by transformed estrogen-receptor complex. Biochem. Biophys. Res. Commun. 46: 661-667.
18. TSAI, S. Y., J. CARLSTEDT-DUKE, N. L. WEIGEL, K. DAHLMAN, J-Å. GUSTAFSSON, M-J. TSAI & B. W. O'MALLEY. 1988. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 55: 361-369.
19. KUMAR, V. & P. CHAMBON. 1988. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145-156.
20. GREENE, G. L., L. E. CLOSS, H. FLEMING, E. R. DESOMBRE & E. V. JENSEN. 1977. Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species. Proc. Natl. Acad. Sci. U.S.A. 74: 3681-3685.
21. GREENE, G. L., C. NOLAN, J. P. ENGLER & E. V. JENSEN. 1980. Monoclonal antibodies to human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 77: 5115-5119.
22. JOAB, I., C. RADANYI, M. RENOIR, T. BUCHOU, M-G. CATELLI, N. BINART, J. MESTER & E-E. BAULIEU. 1984. Common non-hormone binding component in nontransformed chick oviduct receptors of four steroid hormones. Nature 308: 850-853.
23. r 90,000 heat shock protein: an evolving model of ligand-mediated receptor transformation and translocation. Cancer Res. 49: 2222s-2229s.
24. SMITH, D. F. & D. O. TOFT. 1993. Steroid receptors and their associated proteins. Mol. Endocrinol. 7: 4-11.
25. HOLLENBERG, S. M., C. WEINBERGER, E. S. ONG, G. CERELLI, A. ORO, R. LEBO, E. B. THOMPSON, M. G. ROSENFELD & R. M. EVANS. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635-641.
26. GREEN, S. & P. CHAMBON. 1986. A superfamily of potentially oncogenic hormone receptors. Nature 324: 615-617.
27. EVANS, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
28. YAMAMOTO, K. R. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19: 209-252.
29. WEINBERGER, C. & D. J. BRADLEY. 1990. Gene regulation by receptors binding lipid-soluble substances. Annu. Rev. Physiol. 52: 823-840.
30. 3 receptors. Cell 65: 1255-1266.
31. GREEN, S. & P. CHAMBON. 1987. Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature 325: 75-78.
32. AURICCHIO, F. 1989. Phosphorylation of steroid receptors. J. Steroid Biochem. 32: 613-622.
33. ORTI, E., J. E. BODWELL & A. MUNCK. 1992. Phosphorylation of steroid hormone receptors. Endocr. Rev. 13: 105-128.
34. MUNCK, A. & T. BRINCK-JOHNSEN. 1968. Specific and nonspecific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro. J. Biol. Chem. 243: 5556-5565.
35. BEATSON, G. T. 1896. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2: 104-107.
36. HUGGINS, C. & D. M. BERGENSTAL. 1952. Inhibition of human mammary and prostatic cancers by adrenalectomy. Cancer Res. 12: 134-141.
37. LUFT, R. & H. OLIVECRONA. 1953. Experiences with hypophysectomy in man. J. Neurosurg. 10: 301-316.
38. JENSEN, E. V. & E. R. DESOMBRE. 1996. Steroid hormone binding and hormone receptors. In Cancer Medicine. Fourth edition. J. F. Holland, E. Frei III, R. C. Bast, Jr., D. W. Kufe, D. L. Morton & R. R. Weichselbaum, Eds.: Chapter 69. Williams & Wilkins. Baltimore.
39. FOLCA, P. J., R. F. GLASCOCK & W. T. IRVINE. 1961. Studies with tritium-labelled hexoestrol in advanced breast cancer: comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy. Lancet 2: 796-798.
40. JENSEN, E. V., G. E. BLOCK, S. SMITH, K. KYSER & E. R. DESOMBRE. 1971. Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monogr. 34: 55-70.
41. MAASS, H., B. ENGEL, L. HOHMEISTER, F. LEHMANN & G. TRAMS. 1972. Estrogen receptors in human breast cancer tissue. Am. J. Obstet. Gynecol. 113: 377-382.
42. ENGELSMAN, E., J. P. PERSIJN, C. B. KORSTEN & F. J. CLETON. 1973. Oestrogen receptors in human breast cancer tissue and response to endocrine therapy. Br. Med. J. 2: 750-752.
43. LEUNG, B. S., W. S. FLETCHER, T. D. LINDELL, D. C. WOOD & W. W. KRIPPAEHNE. 1973. Predictability of response to endocrine ablation in advanced breast carcinoma. Arch. Surg. 106: 515-519.
44. DESOMBRE, E. R., G. L. GREENE & E. V. JENSEN. 1978. Estrophilin and endocrine responsiveness of breast cancer. In Progress in Cancer Research and Therapy. Vol. 10: Hormones, Receptors, and Breast Cancer. W. L. McGuire, Ed.: 1-14. Raven Press. New York.
45. PUSZTAY, H. M. & E. M. MCDONALD, Eds. 1986. Symposium on estrogen receptor determination with monoclonal antibodies. Cancer Res. 46: 4233s-4313s.
46. MCGUIRE, W. L., G. C. CHAMNESS & S. A. W. FUQUA. 1992. Abnormal estrogen receptor in clinical breast cancer. J. Steroid Biochem. Mol. Biol. 43: 243-247.
47. SLUYSER, M. 1992. Role of receptor variants in the development of hormone resistance in breast cancer. Clin. Biochem. 25: 407-414.
48. FUQUA, S. A. W. & D. M. WOLF. 1995. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res. Treat. 35: 233-241.
49. JORDAN, V. C., W. H. GATHERINO & D. M. WOLF. 1995. A mutant receptor as a mechanism of drug resistance to tamoxifen treatment. Ann. N.Y. Acad. Sci. 761: 138-147.
50. MAHFOUDI, A., E. ROULET, S. DAVOIS, M. G. PARKER & W. WAHLI. 1995. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc. Natl. Acad. Sci. U.S.A. 92: 4206-4210.
51. BLOCK, G. E., R. S. ELLIS, E. DESOMBRE & E. JENSEN. 1978. Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment. Ann. Surg. 188: 372-375.
52. LEAKE, R. E., L. LIANG, K. C. CALMAN, F. R. MACBETH, D. CRAWFORD & D. C. SMITH. 1981. Oestrogen receptor status and endocrine therapy of breast cancer: response rates and status stability. Br. J. Cancer 43: 59-66.
53. HORWITZ, K. B., W. L. MCGUIRE, O. H. PEARSON & A. SEGALOFF. 1975. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189: 726-727.
54. MCGUIRE, W. L. 1978. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol. 5: 428-433.
55. DESOMBRE, E. R., P. P. CARBONE, E. V. JENSEN, W. L. MCGUIRE, S. A. WELLS, JR., J. L. WITTLIFF & M. B. LIPSETT. 1979. Steroid receptors in breast cancer. N. Engl. J. Med. 301: 1011-1012.
56. WALT, A. J., A. SINGHAKOWINTA, S. C. BROOKS & A. CORTEZ. 1976. The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery 80: 506-512.
57. KNIGHT, W. A., III, R. B. LIVINGSTON, E. J. GREGORY & W. L. MCGUIRE. 1977. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 37: 4669-4671.
58. HARPER, M. J. K. & A. L. WALPOLE. 1967. A new derivative of triphenylethylene: effect on implantation and mode of action in rats. J. Reprod. Fertil. 13: 101-119.
59. JORDAN, V. C. & C. S. MURPHY. 1990. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev. 11: 578-610.
60. BLACK, L. J., C. D. JONES & J. F. FALCONE. 1983. Antagonism of estrogen action with a new benzothiophene-derived antiestrogen. Life Sci. 32: 1031-1036.
61. KATZENELLENBOGEN, B. S., K. L. KENDRA, M. J. NORMAN & Y. BERTHOIS. 1987. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 47: 4355-4360.
62. POULIN, R., Y. MERAND, D. POIRIER, C. LEVESQUE, J-M. DUFOUR & F. LABRIE. 1989. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat. 14: 65-76.
63. WAKELING, A. E., M. DUKES & J. BOWLER. 1991. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51: 3867-3873.
64. VAN DE VELDE, P., F. NIQUE, F. BOUCHOUX, J. BRÉMAUD, M-C. HAMEAU, D. LUCAS, C. MORATILLE, S. VIET, D. PHILIBERT & G. TEUTSCH. 1994. RU 58668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. J. Steroid Biochem. Mol. Biol. 48: 187-196.
65. MARTIN, P. M., Y. BERTHOIS & E. V. JENSEN. 1988. Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 85: 2533-2537.
66. BERTHOIS, Y., M. PONS, C. DUSSERT, A. CRASTES DE PAULET & P. M. MARTIN. 1994. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site. Mol. Cell. Endocrinol. 99: 259-268.
67. HEDDEN, A., V. MÜLLER & E. V. JENSEN. 1995. A new interpretation of antiestrogen action. Ann. N.Y. Acad. Sci. 761: 109-120.
68. ECKERT, R. L. & B. S. KATZENELLENBOGEN. 1982. Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. J. Biol. Chem. 257: 8840-8846.